David C. Hohn is Director at CLEVELAND BIOLABS INC (CBLI).
CIK 0001523106
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
| Ticker | Shares | Value |
|---|---|---|
| CBLI | 43,049 | — |
Shares reported on the most recent Form 4, priced at the 2014-03-17 close. 1 holding could not be priced and is excluded from the total.